Vir Biotechnology, Inc.
NASDAQ:VIR
7.15 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
| Operating Activities: | ||||||||
| Net Income
| -521.96 | -615.061 | 515.837 | 528.584 | -298.665 | -174.683 | -115.884 | -69.852 |
| Depreciation & Amortization
| 19.956 | 19.451 | 6.783 | 5.811 | 5.442 | 4.517 | 2.756 | 0.432 |
| Deferred Income Tax
| -2.949 | -1.063 | -15.186 | 15.186 | -0.052 | 14.664 | -0.48 | -10.924 |
| Stock Based Compensation
| 78.457 | 111.316 | 102.082 | 83.784 | 27.6 | 8.719 | 5.053 | 4.782 |
| Change In Working Capital
| 0 | -304.591 | 665.367 | -628.394 | 29.522 | 8.204 | 12.494 | 4.862 |
| Accounts Receivables
| 0 | 0 | 770.038 | -773.079 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 52.815 | 0 | 0 | 0 | 0 |
| Accounts Payables
| -0.988 | 0.732 | 0.797 | -0.171 | -0.79 | 0.964 | 1.471 | 2.011 |
| Other Working Capital
| -76.506 | -305.323 | -105.468 | 92.041 | 30.312 | 7.24 | 11.023 | 2.851 |
| Other Non Cash Items
| -19.856 | 11.163 | 388.37 | -52.56 | 45.212 | 8.947 | 1.965 | 4.319 |
| Operating Cash Flow
| -446.352 | -778.785 | 1,663.253 | -47.589 | -190.941 | -129.632 | -94.096 | -66.381 |
| Investing Activities: | ||||||||
| Investments In Property Plant And Equipment
| -7.301 | -21.573 | -68.028 | -21.817 | -6.549 | -8.94 | -8.192 | -2.742 |
| Acquisitions Net
| 0 | 0 | 0.022 | 140.814 | 0.18 | 247.218 | 0.025 | -27.252 |
| Purchases Of Investments
| -1,235.339 | -2,016.189 | -1,476.965 | -420.24 | -403.841 | -643.898 | -123.105 | 0 |
| Sales Maturities Of Investments
| 1,738.635 | 2,202.391 | 351.51 | 301.243 | 400.348 | 396.68 | 72.574 | 0 |
| Other Investing Activites
| 3.372 | 0 | -1,125.455 | -140.814 | 0.18 | -247.218 | -1.743 | 0 |
| Investing Cash Flow
| 499.367 | 164.629 | -1,193.461 | -140.814 | -9.862 | -256.158 | -60.441 | -29.994 |
| Financing Activities: | ||||||||
| Debt Repayment
| 0 | -0.287 | -0.26 | -0.259 | -0.25 | 4.372 | 0 | 0 |
| Common Stock Issued
| 0 | 7.767 | 28.462 | 85.213 | 529.913 | 126.411 | 24.978 | 271.182 |
| Common Stock Repurchased
| 0 | 0 | 0 | 0 | 0 | -0.003 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 4.388 | 7.767 | 6.559 | 15.377 | -0.189 | 444.875 | 24.978 | 271.182 |
| Financing Cash Flow
| 4.388 | 7.48 | 34.761 | 100.331 | 529.474 | 449.244 | 24.978 | 271.182 |
| Other Information: | ||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 57.403 | -606.676 | 504.553 | -88.072 | 328.671 | 63.454 | -129.559 | 174.807 |
| Cash At End Of Period
| 318.695 | 261.292 | 867.968 | 363.415 | 451.487 | 122.816 | 59.362 | 188.921 |